Advanced Brain Monitoring News
COMMENTARY ADVOCATES WIDESPREAD SCREENING
OF TRUCK DRIVERS FOR OBSTRUCTIVE SLEEP APNEA
[Wednesday, September 5, 2007]
A recent peer-reviewed study conducted by Advanced Brain Monitoring, Inc.
found that as many as 50 percent of transportation workers have undiagnosed
obstructive sleep apnea (OSA), a potentially life-threatening breathing-related
sleep disorder that often goes undiagnosed and untreated. An accompanying
legal article emphasizes the responsibility drivers now have to ensure
they are fit for duty to be socially responsible, avoid tort liability,
and possibly even jail time, if they cause an accident. It also identifies
steps that employers and clinicians can take to reduce the likelihood
of paying punitive damages if a driver has an accident due to OSA. View
full Press
Release.
RELEASE OF 2007 NEWSLETTER
Advanced Brain Monitoring is pleased to present their 2007
Newsletter.
ADVANCED BRAIN MONITORING ARES™ RECEIVES
FROST & SULLIVAN PRODUCT INNOVATION AWARD
[Tuesday, May 22, 2007]
Frost & Sullivan presented Advanced Brain Monitoring, Inc. with the
2006 Product Innovation Award for the Apnea Risk Evaluation System (ARESTM)
in the field of European sleep diagnostics and associated data management
systems market. The Frost & Sullivan Award for Product Innovation
is presented each year to companies that showcase new product introductions.
The honor also recognizes competitive advantage citing unique or revolutionary
technology, acceptance in the marketplace or the value addition of services
to customers. View full Press
Release.
RELEASE OF 2006 NEWSLETTER
Advanced Brain Monitoring is pleased to present their 2006
Newsletter.
ADVANCED BRAIN MONITORING TO PRESENT
AT DENTAL SLEEP MEDICINE CONFERENCE
[Thursday, June 15, 2006]
Dr. Philip Westbrook, Medical Director of Advanced Brain Monitoring, in
collaboration with Dr. Todd Morgan of Scripps Memorial Hospital will present
data validating the efficacy of oral appliance therapy for OSA at the
American Academy of Dental Sleep Medicine annual meeting in Salt Lake
City, UT, June 15-17. The presentation, entitled “In-Home Evaluation
of Efficacy and Titration of a Mandibular Advancement Device for Obstructive
Sleep Apnea”, reports how all subjects, even those suffering from
severe OSA, obtained significant benefits from oral appliance therapy.
ADVANCED
BRAIN MONITORING RECEIVES CE MARK FOR APNEA RISK EVALUATION SYSTEM (ARES)
FOR IN-HOME DIAGNOSIS OF OBSTRUCTIVE SLEEP APNEA
[Monday, February 14, 2005]
Advanced Brain Monitoring, Inc. today announced that it received the CE
Mark in the European Union for its Apnea Risk Evaluation System (ARES).
With this CE Mark, Advanced Brain Monitoring can now market the ARES in
the European Union. The ARES was cleared by the FDA in 2004. The patented
ARES is an easy-to-apply, in-home system for diagnosing obstructive sleep
apnea (OSA). The ARES combines a miniaturized, battery-powered device
to measure blood oxygen levels, pulse rate, snoring sounds, nasal pressure
and head position/movement with a questionnaire to assess known risk factors.
A multi-site clinical trial, including direct comparisons with laboratory
testing and in-home studies on 280 participants, proved ARES was as accurate
as the gold standard laboratory sleep study. View
Press Release.
ADVANCED BRAIN MONITORING TO PARTICIPATE IN 1ST INTERNATIONAL
CONFERENCE ON AUGMENTED COGNITION
[Thursday, July 21, 2005]
Advanced Brain Monitoring, Inc., is pleased to announce its participation
in the 1st International Conference on Augmented Cognition held jointly
with the 11th annual International Conference on Human-Computer Interaction
to be held in Las Vegas, Nevada, from July 22 to 27, 2005, at the Caesars
Palace Hotel and Convention Center. The company will present findings
from recent research on real-time EEG systems that monitor the brain’s
electrical activity to detect fatigue, assess performance, and provide
interactive feedback to the operator. View
Press Release.
ADVANCED
BRAIN MONITORING ANNOUNCES PARTICIPATION IN INTERNATIONAL CONFERENCE ON
FATIGUE MANAGEMENT IN TRANSPORTATION OPERATIONS
[Friday, August 12, 2005]
Advanced Brain Monitoring, Inc., is pleased to present its comprehensive
program for addressing Obstructive Sleep Apnea (OSA) in the workplace
at the 2005 International Conference on Fatigue Management in Transportation
Operations to be held in Seattle, Washington, from September 11 to 15,
2005, at the Sheraton Seattle Hotel and Towers.
“OSA is a highly prevalent disorder and an important preventable
cause of accidents at work and on the road,” commented Dr. Philip
Westbrook, Chief Medical Officer of Advanced Brain Monitoring. “Untreated
OSA can result in daytime drowsiness, memory impairment, and increased
risk for hypertension, diabetes, and cardiovascular disease.” View
Press Release.
STUDY PUBLISHED IN CHEST FINDS APNEA RISK EVALUATION SYSTEM AN
ACCURATE AND COST-EFFECTIVE ALTERNATIVE TO POLYSOMNOGRAPHY
[Wednesday, October 26, 2005]
Advanced Brain Monitoring, Inc., today announced the Apnea Risk Evaluation
System (ARES™) was proven accurate for screening and diagnosis of
obstructive sleep apnea (OSA), according to the study “Description
and Validation of the Apnea Risk Evaluation System: A Novel Method to
Diagnose Sleep Apnea-Hypopnea in the Home” in the October 2005 issue
of CHEST – The Cardiopulmonary and Critical Care Journal.
The multi-site study, funded by the NIH’s National Heart, Lung,
and Blood Institute, was the largest of its kind validating an in-home
system for the diagnosis of OSA, with 284 simultaneous in-lab polysomnography
(PSG) and ARES studies and 187 comparisons of PSG with 2-night unattended
in-home ARES studies. View
Press Release.
FDA CLEARS ADVANCED BRAIN MONITORING’S APNEA RISK EVALUATION
SYSTEM (ARES™) FOR IN-HOME DIAGNOSIS OF OBSTRUCTIVE SLEEP APNEA
[Wednesday, October 20, 2004]
Advanced Brain Monitoring, Inc. today announced it received marketing
clearance from the U.S. Food and Drug Administration (FDA) for its Apnea
Risk Evaluation System (ARES). The patented ARES is an easy-to-apply,
in-home system for diagnosing obstructive sleep apnea (OSA). The ARES
combines a miniaturized, battery-powered device to measure blood oxygen
levels, pulse rate, snoring sounds, nasal pressure and head position/movement
with a questionnaire to assess known risk factors. A multi-site clinical
trial, including direct comparisons with laboratory testing and in-home
studies on 280 participants, proved ARES was as accurate as the gold standard
laboratory sleep study. View
press release.
ADVANCED BRAIN MONITORING AWARDED U.S. PATENT FOR APNEA RISK EVALUATION
SYSTEM (ARES™)
[Monday, October 18, 2004]
Advanced Brain Monitoring has been awarded a U.S. Patent for the Apnea
Risk Evaluation System (ARES), designed for in-home diagnosis of obstructive
sleep apnea. The patent, entitled “Sleep Apnea Risk Evaluation”,
was issued patent number 6,811,538 by the U.S. Patent and Trademark Office.
The ARES combines a miniaturized, battery-powered device to measure blood
oxygen levels, pulse rate, snoring sounds, nasal pressure and head position/movement
with a questionnaire to assess known risk factors. The system includes
the first pulse-oximeter designed specifically to characterize sleep-disordered
breathing. The patent will be issued on November 2, 2004.
INTERNATIONAL JOURNAL OF HUMAN-COMPUTER INTERACTION PUBLISHES
ARTICLE ON ADVANCED BRAIN MONITORING'S EEG SYSTEM
[Tuesday, July 20, 2004]
Future military and industrial applications of Advanced Brain Monitoring’s
EEG system are discussed in the July 2004 issue of the International Journal
of Human-Computer Interaction. The article, “Real-Time Analysis
of EEG Indices of Alertness, Cognition and Memory Acquired with a Wireless
EEG Headset”, presents an integrated solution for mobile acquisition
and real-time analysis of the electroencephalogram (EEG) to monitor indices
of alertness, cognition and memory. The theme of this special issue of
the journal, “Augmented Cognition”, suggests that integration
of physiological monitoring into the man-machine interface holds great
promise for real-time assessment of operator status and intelligent allocation
of tasks between machines and humans.
ADVANCED BRAIN MONITORING TO PRESENT AT SLEEP MEDICINE CONFERENCE
[Thursday, June 03, 2004]
Dr. Philip Westbrook, Medical Director of Advanced Brain Monitoring, will
present data validating the Apnea Risk Evaluation System (ARES) and the
Alertness and Memory Profiling System (AMP) at the Associated Professional
Sleep Societies annual meeting in Philadelphia, PA, June 5 – 10.
The ARES presentation, “A Limited-Channel Single-Site System to
Diagnose Obstructive Sleep Apnea (OSA): Comparison of Full Polysomnography
(PSG) with In-home and In-Lab Recordings”, includes data acquired
from 270 patients and healthy controls to validate the ARES as a system
for diagnosing OSA. The AMP study was designed to identify changes in
alertness and memory in response to treatment of OSA with Continuous Positive
Airway Pressure (CPAP). The presentation, “Quantification of Alertness,
Memory and Neurophysiological Changes in Sleep Apnea Patients Following
Treatment with nCPAP”, reports AMP data acquired from over 100 OSA
patients and healthy controls studied repeatedly over a 3-month period.